Does CABOZANTINIB S-MALATE Cause Hepatic function abnormal? 912 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 912 reports of Hepatic function abnormal have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 2.3% of all adverse event reports for CABOZANTINIB S-MALATE.
912
Reports of Hepatic function abnormal with CABOZANTINIB S-MALATE
2.3%
of all CABOZANTINIB S-MALATE reports
43
Deaths
124
Hospitalizations
How Dangerous Is Hepatic function abnormal From CABOZANTINIB S-MALATE?
Of the 912 reports, 43 (4.7%) resulted in death, 124 (13.6%) required hospitalization, and 13 (1.4%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 912 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
CARBOPLATIN (498)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Hepatic function abnormal Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE